Literature DB >> 2470694

Meibomian gland dysfunction. II. The role of keratinization in a rabbit model of MGD.

J V Jester1, N Nicolaides, I Kiss-Palvolgyi, R E Smith.   

Abstract

Meibomian gland dysfunction (MGD) was induced in 34 albino rabbits by the twice-daily topical application of 2% epinephrine over a period of 6 months to 1 year. Seven age-matched control rabbits, not receiving epinephrine, were followed up for a similar period. All lids were evaluated pre- and post-treatment by gross clinical examination and by transillumination biomicroscopy and photography. Of the 68 rabbit lids evaluated, 56% developed signs of MGD, which ranged from plugging of the meibomian gland orifice and presence of microcysts (subclinical lesions; 30.9% of the lids) to opacification and enlargement of the glands with increasing severity (clinical lesions; 25.0% of the lids). The remaining lids (44%) remained normal. MGD did not develop in the seven control rabbits. After the development of MGD, lids were evaluated by immunofluorescent microscopy, SDS-PAGE and Western blotting using mouse monoclonal antibodies to keratin proteins. Development and progression of MGD in the rabbit appears to correlate with increasing stratification and keratinization of the meibomian gland duct epithelium. In the early stages of MGD, focal areas of epithelial hyperkeratinization were identified by immunohistochemical staining using AE2 monoclonal antibody, specific for the 56.5 kD and 65-67 kD keratin protein marker for keratinized epidermis. As the severity of MGD progressed there was progressive increase in the AE2 staining of the duct epithelium. SDS-PAGE and immunoblotting of proteins from meibomian gland excreta in chronic MGD showed a progressive increase in both the 56.5 kD and 65-67 kD keratinization protein markers during development of MGD. We conclude that hyperkeratinization of the duct epithelium leading to plugging and dilation of the meibomian gland underlies the development of MGD following topical epinephrine treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470694

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

Review 1.  Interventions for chronic blepharitis.

Authors:  Kristina Lindsley; Sueko Matsumura; Elham Hatef; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Meibography: A review of techniques and technologies.

Authors:  Ryan J Wise; Rachel K Sobel; Richard C Allen
Journal:  Saudi J Ophthalmol       Date:  2012-10

Review 3.  Four characteristics and a model of an effective tear film lipid layer (TFLL).

Authors:  P Ewen King-Smith; Melissa D Bailey; Richard J Braun
Journal:  Ocul Surf       Date:  2013-07-12       Impact factor: 5.033

4.  [Meibomian glands : part IV. Functional interactions in the pathogenesis of meibomian gland dysfunction (MGD)].

Authors:  E Knop; N Knop
Journal:  Ophthalmologe       Date:  2009-11       Impact factor: 1.059

Review 5.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

6.  STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis.

Authors:  Matthew J Turner; Sonia DaSilva-Arnold; Na Luo; Xinyao Hu; Callah C West; Lou Sun; Christopher Hill; Joshua Bradish; Mark H Kaplan; Jeffrey B Travers; Yang Sun
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-20       Impact factor: 4.799

7.  Effects of age and dysfunction on human meibomian glands.

Authors:  Chyong Jy Nien; Salina Massei; Gloria Lin; Cameron Nabavi; Jeremiah Tao; Donald J Brown; Jerry R Paugh; James V Jester
Journal:  Arch Ophthalmol       Date:  2011-04

8.  Dry eye after haematopoietic stem cell transplantation.

Authors:  Y Ogawa; S Okamoto; M Wakui; R Watanabe; M Yamada; M Yoshino; M Ono; H Y Yang; Y Mashima; Y Oguchi; Y Ikeda; K Tsubota
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

Review 9.  Androgen and meibomian gland dysfunction: from basic molecular biology to clinical applications.

Authors:  Li-Xiang Wang; Ying-Ping Deng
Journal:  Int J Ophthalmol       Date:  2021-06-18       Impact factor: 1.779

10.  Effect of growth factors on the proliferation and gene expression of human meibomian gland epithelial cells.

Authors:  Shaohui Liu; Wendy R Kam; Juan Ding; Mark P Hatton; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.